Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMGN Amgen

Market Closed 04-02 16:00:00 EDT

347.94

-5.34

-1.51%

盘后347.78

-0.16-0.05%

19:50 EDT

High354.16	Low345.87	Vol1.60M
Open352.72	D1 Closing353.28	Amplitude2.35%
Mkt Cap187.36B	Tradable Cap186.84B	Total Shares538.48M
T/O559.20M	T/O Rate0.30%	Tradable Shares536.99M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"Amgen","latestPrice":347.94,"timestamp":1775160000000,"preClose":353.28,"halted":0,"volume":1604073,"hourTrading":{"tag":"盘后","latestPrice":347.78,"preClose":347.94,"latestTime":"19:50 EDT","volume":84883,"amount":29534431.8886,"timestamp":1775173853358,"change":-0.16,"changeRate":-0.00046,"amplitude":0.002629},"delay":0,"changeRate":-0.015115489130434713,"floatShares":536994627,"shares":538480671,"eps":14.23,"marketStatus":"Market Closed","change":-5.34,"latestTime":"04-02 16:00:00 EDT","open":352.72,"high":354.16,"low":345.87,"amount":559200059.1198,"amplitude":0.023466,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":14.23,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":353.28,"dividendRate":0.027763,"preHourTrading":{"tag":"盘前","latestPrice":351.92,"preClose":353.28,"latestTime":"09:29 EDT","volume":1065,"amount":374983.48605,"timestamp":1775136592096,"change":-1.36,"changeRate":-0.00385,"amplitude":0.023006},"postHourTrading":{"tag":"盘后","latestPrice":347.78,"preClose":347.94,"latestTime":"19:50 EDT","volume":84883,"amount":29534431.8886,"timestamp":1775173853358,"change":-0.16,"changeRate":-0.00046,"amplitude":0.002629},"volumeRatio":0.5997740734823798,"impliedVol":0.3512,"impliedVolPercentile":0.9004},"requestUrl":"/m/hq/s/AMGN","defaultTab":"news","newsList":[{"id":"2624665486","title":"Amgen Expands Thyroid Eye Disease Bet With New AMG 732 Rollover Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2624665486","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624665486?lang=en_us&edition=fundamental","pubTime":"2026-04-04 00:33","pubTimestamp":1775234016,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The new Amgen Inc. rollover study, officially titled “An Open-label, Rollove...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-expands-thyroid-eye-disease-bet-with-new-amg-732-rollover-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-expands-thyroid-eye-disease-bet-with-new-amg-732-rollover-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BGHQF748.EUR","BK4566","LU0320765992.SGD","IE00B3QW5Z07.USD","LU0122379950.USD","BK4585","BK4135","BK4505","BK4139","IE0002141913.USD","LU2242652126.USD","BK4588","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1983299246.USD","BK4534","LU0868494617.USD","SG9999001440.SGD","LU0109394709.USD","LU1061106388.HKD","LU0889565916.HKD","BK4581","LU2242646821.SGD","AMGN","IE0009355771.USD","IE00B2B36J28.USD","LU1571399168.USD","LU2468319806.SGD","LU2112291526.USD","AMG","LU0058720904.USD","LU1023059063.AUD","IE00B64PRP62.GBP","LU1057294990.SGD","BK4599","LU0289739699.SGD","IE00BFTCPJ56.SGD","BK4533","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156527754","title":"Trump Will Impose 100% Tariff on Some Patented Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1156527754","media":"Tiger Newspress","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156527754?lang=en_us&edition=fundamental","pubTime":"2026-04-03 07:16","pubTimestamp":1775171812,"startTime":"0","endTime":"0","summary":"The Trump administration will impose tariffs of as much as 100% on certain imported medicines, albeit with several major exemptions, a maneuver to pressure drugmakers to manufacture more in the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4e63e9b5baa83146ad37e2bf910d1394","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABT","PFE","MRK","JNJ","LLY","AZN","SNY","GSK","BMY","NVAX","VIR","ABBV","REGN","MRNA","NVO","NVS","BIIB","AMGN","BNTX","GILD","VERU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624685740","title":"Amgen's Diversification Continues To Pay Off, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2624685740","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624685740?lang=en_us&edition=fundamental","pubTime":"2026-04-03 01:08","pubTimestamp":1775149730,"startTime":"0","endTime":"0","summary":"Amgen's  pipeline diversification continues to pay off, improving visibility on out-year growth, RBC Capital Markets said in a Thursday note.Among the drivers, the report pointed to its established portfolio, the integrated assets Tepezza, Krystexxa, Uplizna, and emerging pipeline including Imdelltra and MariTide.The report said Repatha, Evenity and Tezspire have all grown between 30% and 50% last year, with Repatha and Evenity still having a long way to go given single-digit penetration in multi-million patient markets.\"AMGN is, in our view, a high quality biotech company on a relative basis as well as from a dividend perspective with steady cash flows and a proven track record,\" the report said, pointing to general medicines, oncology, immunology & inflammation, and rare disease exposures.RBC has an outperform rating with a $360 price target.Price: 347.86, Change: -5.42, Percent Change: -1.53","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2242646821.SGD","IE00B2B36J28.USD","BK4139","SG9999001440.SGD","LU0122379950.USD","LU1057294990.SGD","BK4585","LU2468319806.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0320765992.SGD","LU0889565916.HKD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4533","IE0002141913.USD","LU0868494617.USD","BK4599","LU2242652126.USD","LU1023059063.AUD","LU2112291526.USD","BK4534","LU1061106388.HKD","BK4566","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","BK4581","LU0058720904.USD","AMGN","LU1983299246.USD","IE00BJJMRZ35.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624685615","title":"Amgen Terminates Early-Stage AMG 378 Study: What Investors Should Watch Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2624685615","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624685615?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:30","pubTimestamp":1775147416,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The Phase 1 study “A Phase 1 Randomized, Double-blind, Placebo-controlled, S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-terminates-early-stage-amg-378-study-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-terminates-early-stage-amg-378-study-what-investors-should-watch-next?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN","LU0058720904.USD","SSI","BK4581","LU0889565916.HKD","AMG","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU0320765992.SGD","ISBC","LU1057294990.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4211","BK4533","BK4139","BK4588","IE0002141913.USD","BK4505","BK4566","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2089984988.USD","BK4599","IE00BJJMRZ35.SGD","LU2242652126.USD","LU0868494617.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","LU0109394709.USD","BK4135","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1983299246.USD","BK4534","BK4585","LU0289739699.SGD","IE00BGHQF748.EUR","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158231510","title":"Zai Lab Rises Nearly 5% in Morning Session Following Global Clinical Research Collaboration with Amgen","url":"https://stock-news.laohu8.com/highlight/detail?id=1158231510","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158231510?lang=en_us&edition=fundamental","pubTime":"2026-04-02 11:40","pubTimestamp":1775101249,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) saw an increase of over 4% in morning trading. At the time of writing, the stock was up 4.82%, trading at HK$15.88 with a turnover of HK$288 million. On April 1, Zai Lab announced a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0889565916.HKD","LU1023059063.AUD","LU0058720904.USD","LU0109394709.USD","ZLAB","LU2112291526.USD","IE0002141913.USD","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4581","BK1161","IE0009355771.USD","LU2242652126.USD","BK4585","BK4139","LU0122379950.USD","BK4548","LU1057294990.SGD","LU0320765992.SGD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","09688","LU1061106388.HKD","LU1571399168.USD","IE00B4R5TH58.HKD","BK1574","LU1983299246.USD","IE00B2B36J28.USD","BK4531","AMGN","BK4533","LU2089984988.USD","BK4566","LU0289739699.SGD","BK4526","LU2242646821.SGD","LU2488822045.USD","BK4599","LU0868494617.USD","BK1588","BK4534","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108555307","title":"Zai Lab Shares Climb Over 4% Following Global Clinical Partnership with Amgen for Small Cell Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1108555307","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108555307?lang=en_us&edition=fundamental","pubTime":"2026-04-02 09:52","pubTimestamp":1775094739,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) rose more than 4% in Hong Kong trading, with the stock up 4.22% to HK$15.79 by the time of writing, as turnover reached HK$98.01 million. The increase follows an announcement on April...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2242652126.USD","LU0289739699.SGD","VXUS","IE0002141913.USD","BK4566","LU2468319806.SGD","09688","BK4588","LU1023059063.AUD","ZLAB","BK4548","BK4531","BK4139","LU0320765992.SGD","IE0009355771.USD","LU1983299246.USD","LU2112291526.USD","LU2488822045.USD","IE00BJT1NW94.SGD","SG9999001440.SGD","BK4534","LU0122379950.USD","BK4599","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","BK1574","LU1571399168.USD","LU1061106388.HKD","IE00B2B36J28.USD","LU2242646821.SGD","AMGN","IE00BJJMRZ35.SGD","BK4581","LU2089984988.USD","LU1057294990.SGD","BK1588","LU0058720904.USD","BK4533","LU0109394709.USD","BK1161","LU0868494617.USD","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624054992","title":"Why 2026 Is Biotech's Comeback Year -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2624054992","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624054992?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:07","pubTimestamp":1775074020,"startTime":"0","endTime":"0","summary":"About the author:  Nilesh Kumar is head of biotech private investments at Wellington Management.As pharmaceutical companies raced to develop a Covid-19 vaccine in 2020, the biotech industry boomed. Investors eager to capitalize on the momentum poured money into biotech companies and sought opportunities to back new drugs, regardless of where they were on the path to clinical success and regulatory approval.At the peak of the biotech boom in 2021, more than half of the 104 companies that went public in the U.S. were either preclinical or in Phase 1 trials -- the earliest stages of testing for new medicines -- and therefore the most speculative stage from an investment standpoint. By 2024, the number of new offerings had dwindled to 24. Last year, only 11 biotech companies joined the market. Just one was a company whose leading drug candidate was in early-stage trials.The launch in January of the first oral obesity drug by Novo Nordisk was the beginning of several new obesity treatments ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU0823416689.USD","LU0225771236.USD","SG9999001440.SGD","BK4599","LU2242652126.USD","SG9999002232.USD","LU2471134523.USD","LU2237438978.USD","IE0005OL40V9.USD","IE00BBT3K403.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BKDWB100.SGD","LU0316494557.USD","LU0820561818.USD","LU0158827781.USD","LU1366192091.USD","LU1883839398.USD","LU0006306889.USD","LU0079474960.USD","IE00BK4W5L77.USD","LU2237443382.USD","XBI","BK4532","IE0002270589.USD","LU2023251221.USD","LU1093756325.SGD","IE00B7KXQ091.USD","LU1974910355.USD","LU2063271972.USD","BK4566","LU0683600562.USD","IE00BFSS7M15.SGD","LU1066051498.USD","LU2242646821.SGD","NVOH","LU2896262040.SGD","LU1291159041.SGD","04332","BK4581","LU1035775433.USD","LU2089283258.USD","LU0256863902.USD","LU2111349929.HKD","SG9999015952.SGD","IE00BLSP4239.USD","LU2361044865.SGD","LLII","LU1720051017.SGD","LU0106261372.USD","LU2264538146.SGD","LU0158827948.USD","LU1868837300.USD","LU1983299246.USD","ELIS","IE0004445015.USD","LU2108987350.USD","IE000M9KFDE8.USD","LU1868836914.USD","LU2168564065.EUR","SG9999014906.USD","IE00B4JS1V06.HKD","LU2237443549.SGD","LU1232071149.USD","IE0001KFT4U8.USD","LU1814569148.SGD","LU1057294990.SGD","BK4550","LU2746668974.SGD","LU2552382058.USD","IE00B19Z3581.USD","LU2756315664.SGD","LU0097036916.USD","LU2360106947.USD","LU0238689110.USD","IE00BJT1NW94.SGD","LU0672654240.SGD","LU0203201768.USD","LU0323591593.USD","LU2746668461.USD","LU1127390331.HKD","LU1868837136.USD","LU0456855351.SGD","LU2237443895.HKD","LU2211815571.USD","LU0689472784.USD","LU1145028129.USD","IE0004445239.USD","LU1551013342.USD","LU2237443465.HKD","SG9999017495.SGD","LU2552382215.SGD","BK4139","LU2461242641.AUD","SG9999015986.USD","BK4585","IE00B19Z3B42.SGD","IE00B1XK9C88.USD","LU0820562030.AUD","LU1804176565.USD","SG9999013999.USD","LU0256863811.USD","LU2089284900.SGD","SG9999014880.SGD","IE00BFTCPJ56.SGD","IE00BN29S564.USD","LU2168564149.EUR","LU2168563687.JPY","LU0203202063.USD","LU0985481810.HKD","LU1066053197.SGD","LU2271345857.HKD","LU1989771016.USD","IE00BJLML261.HKD","LU1712237335.SGD","LU0109394709.USD","SG9999018865.SGD","BK4516","LU0321505868.SGD","LU0306806265.USD","LU1917777945.USD","SG9999001176.SGD","LU0786609619.USD","LU0354030438.USD","SG9999011175.SGD","LU0823434740.USD","LU1868836591.USD","LU0640476718.USD","LU0354030511.USD","LU2237443978.SGD","IE00BJJMRY28.SGD","LU0061475181.USD","LU2471134879.HKD","IE0009355771.USD","LU2087625088.SGD","LU2237443622.USD","LLYX","LU2468319806.SGD","LU2750360997.AUD","LU1988902786.USD","LU2023250504.SGD","SG9999014898.SGD","LU1061106388.HKD","LLYZ","LU0320765992.SGD","LU2028103732.USD","LU2236285917.USD","LU2417539215.USD","LU0964807845.USD","LU2106854487.HKD","LU0289739699.SGD","LU2265009873.SGD","LU2168564222.USD","LU0432979614.USD","IE00BZ1G4Q59.USD","IE00B2B36J28.USD","LU0353189680.USD","LU0471298694.HKD","SG9999015945.SGD","LU0868494617.USD","LU1894683264.USD","LU2361045086.USD","SGXZ31699556.SGD","LU2471134796.USD","IE00B775H168.HKD","BK4533","LU0058720904.USD","LU1548497426.USD","LU0225283273.USD","LU0320765059.SGD","LU2552382132.HKD","LU2089984988.USD","IE00B1BXHZ80.USD","LU0170899867.USD","LU2456880835.USD","LU1551013425.SGD","LU2602419157.SGD","LU0466842654.USD","SG9999001176.USD","SGXZ99366536.SGD","LU0321505439.SGD","LU1069344957.HKD","BK4588","LU0708995401.HKD","LU0096364046.USD","LU1629891620.HKD","SGXZ57979304.SGD","BK4007","LU0225284248.USD","LU0787776722.HKD","LU1064131342.USD","PFE","SG9999018857.SGD","LU0234572021.USD","LU0306807586.USD","AMGN","LU2462157665.USD","LU0943347566.SGD","LU2491049909.HKD","SG9999014914.USD","LU0198837287.USD","BK4592","LU2023250330.USD","IE00BKVL7J92.USD","LU2112291526.USD","LU0109391861.USD","LU0114720955.EUR","LU1093756168.USD","LU0094547139.USD","SG9999002224.SGD","LU0882574139.USD","LU0417517546.SGD","LU2491050071.SGD","LU1623119135.USD","LU2168564495.EUR","LU2357305700.SGD","LU0471298777.SGD","LU2491050154.USD","LU0889565916.HKD","SG9999015978.USD","SGXZ81514606.USD","LU0820561909.HKD","LLY","LU2324357040.USD","IE0002141913.USD","NVO","BK4534","IE00BJJMRX11.SGD","LU0122379950.USD","ELIL","SGXZ51526630.SGD","LU0353189763.USD","NVOX","IE00BK4W5M84.HKD","LU1267930730.SGD","BK4568","LU1571399168.USD","IE00BFSS8Q28.SGD","LU1323610961.USD","LU0210536198.USD","LU0882574055.USD","LU1280957306.USD","LU2750360641.GBP","LU2471134952.CNY","LU2213496289.HKD","LU0385154629.USD","IE00BLSP4452.SGD","LU1894683348.USD","LU2756315318.SGD","IE00BKPKM429.USD","LU0266013472.USD","LU0154236417.USD","LU0823434583.USD","LU1720051108.HKD","LU2361044949.HKD","LU1868836757.USD","SG9999003800.SGD","GB00BDT5M118.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624165515","title":"BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2624165515","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624165515?lang=en_us&edition=fundamental","pubTime":"2026-04-01 20:34","pubTimestamp":1775046889,"startTime":"0","endTime":"0","summary":"BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager TherapyZai Lab Ltd ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAQW7D2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","BK4599","LU2468319806.SGD","LU0868494617.USD","BK4585","LU0122379950.USD","LU2488822045.USD","IE0009355771.USD","LU2242652126.USD","IE00B4R5TH58.HKD","BK1574","LU0109394709.USD","LU2089984988.USD","IE00BJT1NW94.SGD","BK1161","LU2112291526.USD","IE00B2B36J28.USD","BK4534","BK4566","LU0320765992.SGD","LU1983299246.USD","BK4533","BK1588","LU1023059063.AUD","LU0058720904.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4588","BK4139","LU0289739699.SGD","LU0889565916.HKD","LU1057294990.SGD","BK4581","LU1571399168.USD","LU1061106388.HKD","09688","IE0002141913.USD","AMGN","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624259003","title":"Zai Lab, Amgen partner on global trial of DLL3 ADC with Imdelltra in SCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2624259003","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624259003?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:31","pubTimestamp":1775043072,"startTime":"0","endTime":"0","summary":"Zai Lab entered global clinical trial collaboration with Amgen to test DLL3-targeting ADC zocilurtatug pelitecan with Amgen’s IMDELLTRA in extensive-stage small cell lung cancer.Amgen will sponsor and run global Phase 1b study evaluating safety, efficacy of combination.Zai Lab will retain full ownership of zocilurtatug pelitecan.Agreement includes supply arrangement under which Zai Lab will provide study drug to Amgen.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL4kTWhs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1588","BK1161","LU1983299246.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1571399168.USD","IE0009355771.USD","LU2112291526.USD","LU0122379950.USD","BK4533","LU0320765992.SGD","BK4566","LU1057294990.SGD","BK1574","LU0289739699.SGD","SG9999001440.SGD","LU0889565916.HKD","LU2488822045.USD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU0868494617.USD","BK4585","LU2468319806.SGD","LU1023059063.AUD","LU2242652126.USD","LU2089984988.USD","BK4534","09688","IE0002141913.USD","LU0058720904.USD","BK4581","BK4599","LU1061106388.HKD","BK4588","AMGN","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624716590","title":"Zai Lab Ltd - Announces Global Clinical Trial Collaboration With Amgen for Es-Sclc","url":"https://stock-news.laohu8.com/highlight/detail?id=2624716590","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624716590?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:30","pubTimestamp":1775043001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nTUAQW7D2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4588","LU0122379950.USD","LU1023059063.AUD","LU1061106388.HKD","09688","LU1571399168.USD","IE00B2B36J28.USD","BK4534","BK4585","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU0889565916.HKD","LU2112291526.USD","BK4139","AMGN","LU2242646821.SGD","SG9999001440.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU2488822045.USD","BK1588","BK4566","LU0868494617.USD","LU0320765992.SGD","LU0289739699.SGD","BK1161","BK4599","LU1983299246.USD","BK4581","LU0109394709.USD","LU2242652126.USD","BK4533","IE0009355771.USD","LU2468319806.SGD","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624590154","title":"Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624590154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624590154?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:16","pubTimestamp":1775042175,"startTime":"0","endTime":"0","summary":"In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Amgen, with a price target of $432.00. According to TipRan...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-reaffirms-their-buy-rating-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624959745","title":"Wells Fargo Gives a Hold Rating to Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624959745","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624959745?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:57","pubTimestamp":1775041060,"startTime":"0","endTime":"0","summary":"In a report released today, Mohit Bansal from Wells Fargo assigned a Hold rating to Amgen, with a price target of $390.00. Bansal covers the Health...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wells-fargo-gives-a-hold-rating-to-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wells-fargo-gives-a-hold-rating-to-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624356186","title":"Genmab names Margarida Duarte general manager for Europe and emerging markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2624356186","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624356186?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:07","pubTimestamp":1775020077,"startTime":"0","endTime":"0","summary":"Genmab appointed Margarida Duarte as general manager for Europe and emerging markets as it expands commercial operations in the region.Duarte will lead commercial strategy and execution across those markets, including preparation for upcoming product launches.She most recently served as executive vice president and chief commercial officer at Deciphera Pharmaceuticals, overseeing commercialization in US and Europe.Earlier roles included leadership positions at Alnylam Pharmaceuticals, Exelixis, Onyx Pharmaceuticals, and Amgen.Duarte will be based in Zug and report to Genmab Chief Commercial Officer Brad Bailey.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genmab A/S published the original content used to generate this news brief on A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL2CZMzP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0058720904.USD","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU1057294990.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4588","BK4533","BK4139","LU0114720955.EUR","LU0882574055.USD","ALNY","IE0002141913.USD","BK4566","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2089984988.USD","BK4599","IE00BJJMRZ35.SGD","LU2242652126.USD","EXEL","LU0868494617.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","LU0109394709.USD","BK4532","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1983299246.USD","BK4534","BK4585","LU0289739699.SGD","SG9999001440.SGD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624737559","title":"Amgen announces availability of 2025 shareholder letter and annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2624737559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624737559?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:48","pubTimestamp":1774997324,"startTime":"0","endTime":"0","summary":"Amgen announced availability of Bob Bradway’s 2025 letter to shareholders, dated March 18, 2026, outlining strategy focused on innovation, disciplined execution, and resilience amid scientific, economic, and geopolitical change.Letter reported 2025 total revenue rose 10% to USD 37 billion, non-GAAP EPS increased to USD 22, free cash flow reached USD 8.1 billion.Dividend payments totaled USD 5.1 billion, supported by a 6% increase in quarterly dividend over 2024, extending dividend-growth streak to 14 years.Amgen said it invested about USD 7.3 billion in R&D, with a larger share directed to later-stage clinical programs as more assets advanced through development.Letter highlighted biosimilar sales of USD 3 billion in 2025, up 37%, alongside launch of direct-to-patient AmgenNow program covering Repatha, Aimovig, Amjevita.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL55LRht:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","LU0058720904.USD","BK4581","LU0889565916.HKD","LU0320765992.SGD","LU1057294990.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4588","BK4533","BK4139","IE0002141913.USD","BK4566","LU1571399168.USD","LU2112291526.USD","LU1023059063.AUD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2089984988.USD","BK4599","IE00BJJMRZ35.SGD","LU2242652126.USD","LU0868494617.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1983299246.USD","BK4534","BK4585","LU0289739699.SGD","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624555692","title":"Amgen publishes 2025 annual report, revenue rises 10% to $37 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2624555692","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624555692?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:09","pubTimestamp":1774994989,"startTime":"0","endTime":"0","summary":"Amgen published its annual report for fiscal 2025, highlighting broad-based demand across its portfolio and record sales for multiple medicines.Management signaled 2026 focus on late-stage clinical data generation, led by Phase 3 program for obesity candidate MariTide.Report emphasized pipeline momentum from label expansions and new indications across key brands, including Repatha, UPLIZNA, TEZSPIRE.Company outlined stepped-up manufacturing and innovation buildout, citing capital investment of about USD 1.9 billion.Amgen launched direct-to-patient access program AmgenNow in October 2025, expanding it in December to lower out-of-pocket costs for eligible patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDLNjjs3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU0109394709.USD","BK4534","LU1057294990.SGD","LU2242646821.SGD","LU0122379950.USD","BK4566","BK4599","IE0002141913.USD","SG9999001440.SGD","LU0889565916.HKD","IE0009355771.USD","IE00B4R5TH58.HKD","LU1571399168.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765992.SGD","LU2468319806.SGD","LU0289739699.SGD","LU2112291526.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","BK4581","IE00BJJMRZ35.SGD","LU2089984988.USD","BK4588","LU0868494617.USD","LU2242652126.USD","BK4533","AMGN","BK4585","LU1983299246.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624534381","title":"Bernstein Reaffirms Their Hold Rating on Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624534381","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624534381?lang=en_us&edition=fundamental","pubTime":"2026-04-01 02:18","pubTimestamp":1774981126,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on Amgen, with a price target of $335.00. According to TipRa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-hold-rating-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-reaffirms-their-hold-rating-on-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623381465","title":"FDA Says Amgen's Tavneos Linked to Liver Injuries, Deaths","url":"https://stock-news.laohu8.com/highlight/detail?id=2623381465","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623381465?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:51","pubTimestamp":1774968660,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration said Tavneos, an Amgen drug used to  treat a group of rare diseases that cause blood vessel inflammation, has been linked to dozens of cases of serious liver injuries, including eight deaths.The FDA said it has identified 76 cases of drug-induced liver injuries with reasonable evidence of being causally linked to Tavneos. Of those, 74 cases reported serious outcomes, including eight deaths and 54 hospitalizations.Some cases involved vanishing bile duct syndrome, a liver condition characterized by the progressive destruction of bile ducts in the liver, the agency said.The cases \"represent new safety concerns\" around Tavneos, known generically as avacopan, the FDA said, adding that it continues to monitor post-marketing cases of DILI and VBDS involving the drug.Amgen did not immediately respond to a request for comment.The FDA had asked Amgen to pull Tavneos from the U.S. market in January, citing some methodological concerns about a previous clinical tri","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1983299246.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1571399168.USD","IE0009355771.USD","LU2112291526.USD","LU0122379950.USD","BK4533","LU0320765992.SGD","BK4566","LU1057294990.SGD","LU0289739699.SGD","SG9999001440.SGD","LABU","LU0889565916.HKD","LU2242646821.SGD","IE00BJT1NW94.SGD","LU0868494617.USD","BK4585","LU2468319806.SGD","LU1023059063.AUD","LU2242652126.USD","LU2089984988.USD","BK4534","IE0002141913.USD","LU0058720904.USD","BK4581","BK4599","LU1061106388.HKD","BK4588","AMGN","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623584213","title":"FDA: Vanishing Bile Duct Syndrome & Drug-Induced Liver Injury Cases With Fatal Outcomes Represent New Safety Concerns for Tavneos - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2623584213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623584213?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:04","pubTimestamp":1774962288,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J0ZP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0122379950.USD","BK4534","IE00BJT1NW94.SGD","BK4533","LU0109394709.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","AMGN","IE00B4R5TH58.HKD","LU0889565916.HKD","LU1571399168.USD","BK4139","LU2112291526.USD","BK4588","LU1023059063.AUD","BK4581","LU1983299246.USD","BK4585","LU1061106388.HKD","LU2089984988.USD","LU0058720904.USD","IE00B2B36J28.USD","LU0289739699.SGD","LU2242646821.SGD","BK4599","BK4566","IE0009355771.USD","SG9999001440.SGD","LU1057294990.SGD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623970308","title":"REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policies","url":"https://stock-news.laohu8.com/highlight/detail?id=2623970308","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623970308?lang=en_us&edition=fundamental","pubTime":"2026-03-31 14:00","pubTimestamp":1774936800,"startTime":"0","endTime":"0","summary":"REFILE-FOCUS-Drugmakers delay some European launches with a wary eye on Trump's pricing policiesCorrects typographical error in anti-inflammatory drug name Brinsupri in paragraph 15Trump most-favored-nation deals cause pricing uncertaintyData shows 35% drop in European new drug launchesCompanies say they want more clarity on US prices first Situation bolsters US position as first go-to marketEurope needs to rethink drug pricing to stay competitive, lobby group saysBy Maggie Fick, Bhanvi Satija and Dominique Patton","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL4N40D163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INDV","LU1496350171.SGD","LU1487256676.USD","LU0047473722.SGD","LU0077335932.USD","LU0868494617.USD","LU0963555726.SGD","LU0310800379.SGD","LU1153584641.USD","LU0211326839.USD","LU1170363599.USD","IE00B3T34201.USD","AZN.UK","LU0949170426.SGD","LU2112291526.USD","LU0792757196.USD","LU1989772923.USD","LU1291159041.SGD","SG9999001176.SGD","INSM","LU0889565080.SGD","AMGN","LU1989771016.USD","LU2089984988.USD","LU1196032939.SGD","LU0972486137.USD","LU0266013472.USD","LU1064927863.SGD","LU0211327993.USD","LU2125909593.SGD","LU0496365809.HKD","LU0545039389.USD","LU1301847155.USD","LU2108987350.USD","LU1880407132.USD","LU2242652126.USD","03165","LU2089283258.USD","LU0320765992.SGD","BK4533","LU1983299246.USD","LU0823416689.USD","SG9999001176.USD","LU1153585028.USD","LU0029864427.USD","LU2293690082.USD","LU0960981461.USD","LU0047473722.EUR","BK4566","LU0345777659.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623137453","title":"Amgen Says Repatha Reduced Major Cardiovascular Event Risk by 31% in Diabetes Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2623137453","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623137453?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:43","pubTimestamp":1774863789,"startTime":"0","endTime":"0","summary":"Amgen (AMGN) said Saturday that its cholesterol-lowering drug Repatha reduced the risk of first major cardiovascular events by 31% in high-risk diabetes patients without known significant atherosclero","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2242652126.USD","BK4599","LU0868494617.USD","BK4566","LU1061106388.HKD","LU2089984988.USD","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1571399168.USD","SG9999001440.SGD","BK4581","BK4533","IE00B2B36J28.USD","CSII","BK4082","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2242646821.SGD","BK4534","LU1023059063.AUD","BK4585","LU2112291526.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","LU0289739699.SGD","AMGN","BK4588","LU0109394709.USD","BK4139","LU1983299246.USD","LU0122379950.USD","LU0889565916.HKD","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":-0.0148},{"period":"1month","weight":-0.0771},{"period":"3month","weight":0.062},{"period":"6month","weight":0.168},{"period":"1year","weight":0.1382},{"period":"ytd","weight":0.063}],"compareEarnings":[{"period":"1week","weight":0.0166},{"period":"1month","weight":-0.036},{"period":"3month","weight":-0.04},{"period":"6month","weight":-0.02},{"period":"1year","weight":0.1617},{"period":"ytd","weight":-0.0383}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and delivers medicines for the toughest diseases. It focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve people’s lives. It operates in the human therapeutics segment. Its marketed products portfolio includes EPOGEN (epoetin alfa); Aranesp (darbepoetin alfa); Parsabiv (etelcalcetide); Neulasta (pegfilgrastim); KANJINTI (trastuzumab-anns); Otezla; BLINCYTO (blinatumomab); ACTIMMUNE (interferon gamma-1b); Neulasta (pegfilgrastim); Sensipar/Mimpara (cinacalcet); Prolia (denosumab); ENBREL; QUINSAIR (levofloxacin); Repatha (evolocumab) and others. It markets ENBREL, a tumor necrosis factor blocker, in the United States and Canada. It markets Otezla, a small molecule that inhibits phosphodiesterase 4, in many countries around the world. It markets Repatha, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in many countries around the world.","yearOnYearQuotes":[{"month":1,"riseRate":0.651163,"avgChangeRate":0.034336},{"month":2,"riseRate":0.488372,"avgChangeRate":0.00202},{"month":3,"riseRate":0.511628,"avgChangeRate":0.016602},{"month":4,"riseRate":0.44186,"avgChangeRate":-0.003044},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.021538},{"month":11,"riseRate":0.627907,"avgChangeRate":0.022348},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045446}],"exchange":"NASDAQ","name":"Amgen","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.39.0","shortVersion":"4.39.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amgen,AMGN,Amgen股票,Amgen股票老虎,Amgen股票老虎国际,Amgen行情,Amgen股票行情,Amgen股价,Amgen股市,Amgen股票价格,Amgen股票交易,Amgen股票购买,Amgen股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amgen(AMGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amgen(AMGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}